Companies › PSTV
PLUS THERAPEUTICS INC (PSTV)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001095981 · EDGAR filings · Updated 2026-07-01
PLUS THERAPEUTICS INC (PSTV) has reported institutional ownership of 5.3%, with 24 institutional managers holding positions valued at $1.49M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, PLUS THERAPEUTICS INC has 24 institutional holders and institutional ownership of 5.3%.
Insider activity
Insiders reported 6 transactions (2 buys, 0 sells) across 5 reporting insiders, with a net reported value of $64.1K.
Data flags from SEC filings
Related companies
REGENTIS BIOMATERIALS LTD (RGNT) · Retractable Technologies Inc (RVP) · Imunon Inc (IMNN) · Turn Therapeutics Inc (TTRX) · BioVie Inc (BIVI) · QUINCE THERAPEUTICS (QNCX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.